Cite
HARVARD Citation
Lenti, M. et al. (2018). A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study. Digestive and liver disease. 50 (12), pp. 1299-1304. [Online].